Diferencia entre revisiones de «Antivirals»
Sin resumen de edición |
Sin resumen de edición |
||
| (No se muestran 13 ediciones intermedias de 5 usuarios) | |||
| Línea 1: | Línea 1: | ||
==Anti-herpetic agents== | ==Anti-herpetic agents== | ||
*[[Acyclovir]] | *[[Acyclovir]] | ||
*[[Famciclovir]] | |||
*[[Foscarnet]] | |||
*[[Ganciclovir]] | |||
*[[Valacyclovir]] | *[[Valacyclovir]] | ||
*[[Valganciclovir]] | |||
==Anti-influenza agents== | ==Anti-influenza agents== | ||
===Adamantane Derivatives=== | ===Adamantane Derivatives=== | ||
*Amantadine | *[[Amantadine]] | ||
*Rimantadine | *[[Rimantadine]] | ||
===Neuraminidase Inhibitors=== | ===Neuraminidase Inhibitors=== | ||
*Oseltamivir | *[[Oseltamivir]] | ||
*Peramivir | *[[Peramivir]] | ||
*Zanamivir | *[[Zanamivir]] | ||
==Interferons | ===Endonuclease Inhibitors=== | ||
*Interferon-α | *[[Baloxavir marboxil]] | ||
==Interferons== | |||
*[[Interferon-α]] | |||
==HAART== | ==HAART== | ||
*HIV regimen that typically consists of combination of 2 nucleoside and/or non-nucleoside reverse transcriptase inhibitors PLUS a protease inhibitor, reverse-transcriptase inhibitor, or integrase inhibitor | |||
*US DHHS first-line regimens | |||
**[[Emtricitabine/tenofovir]] (Truvada) + raltegravir | |||
**[[Emtricitabine/tenofovir]] + dolutegravir | |||
**[[Abacavir/lamivudine]] (Epzicom) + dolutegravir '''OR''' [[abacavir/lamivudine]]/dolutegravir (Triumeq) | |||
**[[Emtricitabine/tenofovir]]/elvitegravir/cobicistat (Stribild) | |||
**[[Emtricitabine/tenofovir]] + ritonavir + darunavir | |||
*WHO first-line regimen | |||
**[[Emtricitabine/tenofovir]]/efavirenz (Atripla) | |||
**Tenofovir + lamivudine + efavirenz | |||
==Other== | |||
*[[Ribavirin]] | |||
==See Also== | ==See Also== | ||
| Línea 25: | Línea 45: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] [[Category:ID]] | ||
Revisión actual - 14:52 18 mar 2020
Anti-herpetic agents
Anti-influenza agents
Adamantane Derivatives
Neuraminidase Inhibitors
Endonuclease Inhibitors
Interferons
HAART
- HIV regimen that typically consists of combination of 2 nucleoside and/or non-nucleoside reverse transcriptase inhibitors PLUS a protease inhibitor, reverse-transcriptase inhibitor, or integrase inhibitor
- US DHHS first-line regimens
- Emtricitabine/tenofovir (Truvada) + raltegravir
- Emtricitabine/tenofovir + dolutegravir
- Abacavir/lamivudine (Epzicom) + dolutegravir OR abacavir/lamivudine/dolutegravir (Triumeq)
- Emtricitabine/tenofovir/elvitegravir/cobicistat (Stribild)
- Emtricitabine/tenofovir + ritonavir + darunavir
- WHO first-line regimen
- Emtricitabine/tenofovir/efavirenz (Atripla)
- Tenofovir + lamivudine + efavirenz